Simões S - Search Results

1

Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.

Gomes-da-Silva LC, Simões S, Moreira JN. Gomes-da-Silva LC, et al. Among authors: simoes s. Cell Mol Life Sci. 2014 Apr;71(8):1417-38. doi: 10.1007/s00018-013-1502-2. Epub 2013 Nov 13. Cell Mol Life Sci. 2014. PMID: 24221135 Free PMC article. Review.

2

Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.

Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simões S, Moreira JN. Gomes-da-Silva LC, et al. Among authors: simoes s. Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8. Acc Chem Res. 2012. PMID: 22568781

3

Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment.

Gomes-da-Silva LC, Santos AO, Bimbo LM, Moura V, Ramalho JS, Pedroso de Lima MC, Simões S, Moreira JN. Gomes-da-Silva LC, et al. Among authors: simoes s. Int J Pharm. 2012 Sep 15;434(1-2):9-19. doi: 10.1016/j.ijpharm.2012.05.018. Epub 2012 May 19. Int J Pharm. 2012. PMID: 22617794

4

Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.

Gomes-da-Silva LC, Fernández Y, Abasolo I, Schwartz S Jr, Ramalho JS, Pedroso de Lima MC, Simões S, Moreira JN. Gomes-da-Silva LC, et al. Among authors: simoes s. Nanomedicine (Lond). 2013 Sep;8(9):1397-413. doi: 10.2217/nnm.12.174. Epub 2013 Feb 8. Nanomedicine (Lond). 2013. PMID: 23394132

5

Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.

Gomes-da-Silva LC, Ramalho JS, Pedroso de Lima MC, Simões S, Moreira JN. Gomes-da-Silva LC, et al. Among authors: simoes s. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):356-64. doi: 10.1016/j.ejpb.2013.04.007. Epub 2013 May 7. Eur J Pharm Biopharm. 2013. PMID: 23659854

6

Bridging cancer biology and the patients' needs with nanotechnology-based approaches.

Fonseca NA, Gregório AC, Valério-Fernandes A, Simões S, Moreira JN. Fonseca NA, et al. Among authors: simoes s. Cancer Treat Rev. 2014 Jun;40(5):626-35. doi: 10.1016/j.ctrv.2014.02.002. Epub 2014 Feb 22. Cancer Treat Rev. 2014. PMID: 24613464 Review.

7

On the formulation of pH-sensitive liposomes with long circulation times.

Simões S, Moreira JN, Fonseca C, Düzgüneş N, de Lima MC. Simões S, et al. Adv Drug Deliv Rev. 2004 Apr 23;56(7):947-65. doi: 10.1016/j.addr.2003.10.038. Adv Drug Deliv Rev. 2004. PMID: 15066754 Review.

8

Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical reality.

Moreira JN, Santos A, Simões S. Moreira JN, et al. Among authors: simoes s. Rev Recent Clin Trials. 2006 Sep;1(3):217-35. doi: 10.2174/157488706778250050. Rev Recent Clin Trials. 2006. PMID: 18473975 Review.

9

Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.

Mendonça LS, Firmino F, Moreira JN, Pedroso de Lima MC, Simões S. Mendonça LS, et al. Among authors: simoes s. Bioconjug Chem. 2010 Jan;21(1):157-68. doi: 10.1021/bc9004365. Bioconjug Chem. 2010. PMID: 20000596

10

Design of peptide-targeted liposomes containing nucleic acids.

Santos AO, da Silva LC, Bimbo LM, de Lima MC, Simões S, Moreira JN. Santos AO, et al. Among authors: simoes s. Biochim Biophys Acta. 2010 Mar;1798(3):433-41. doi: 10.1016/j.bbamem.2009.12.001. Epub 2009 Dec 11. Biochim Biophys Acta. 2010. PMID: 20004174 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters